These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 29277750)
1. The Role of Prophylactic Cranial Irradiation for Non-small Cell Lung Cancer. Precival C; Landy M; Poole C; Mullaney L Anticancer Res; 2018 Jan; 38(1):7-14. PubMed ID: 29277750 [TBL] [Abstract][Full Text] [Related]
2. Treatment and toxic effects of prophylactic cranial irradiation in stage II-III non-small cell lung cancer: A meta-analysis. Li M; Wang T; Wen P; Wang X; Wu C Asia Pac J Clin Oncol; 2021 Apr; 17(2):e18-e26. PubMed ID: 32761788 [TBL] [Abstract][Full Text] [Related]
3. Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: a Cochrane Review. Lester JF; MacBeth FR; Coles B Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):690-4. PubMed ID: 15913909 [TBL] [Abstract][Full Text] [Related]
5. Prophylactic Cranial Irradiation vs Observation in Patients With Locally Advanced Non-Small Cell Lung Cancer: A Long-term Update of the NRG Oncology/RTOG 0214 Phase 3 Randomized Clinical Trial. Sun A; Hu C; Wong SJ; Gore E; Videtic G; Dutta S; Suntharalingam M; Chen Y; Gaspar LE; Choy H JAMA Oncol; 2019 Jun; 5(6):847-855. PubMed ID: 30869743 [TBL] [Abstract][Full Text] [Related]
6. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. Sun A; Bae K; Gore EM; Movsas B; Wong SJ; Meyers CA; Bonner JA; Schild SE; Gaspar LE; Bogart JA; Werner-Wasik M; Choy H J Clin Oncol; 2011 Jan; 29(3):279-86. PubMed ID: 21135267 [TBL] [Abstract][Full Text] [Related]
7. Prophylactic cranial irradiation in locally advanced non-small cell lung cancer: outcome of recursive partitioning analysis group 1 patients. Yavuz AA; Topkan E; Onal C; Yavuz MN J Exp Clin Cancer Res; 2008 Dec; 27(1):80. PubMed ID: 19055787 [TBL] [Abstract][Full Text] [Related]
8. Prophylactic Cranial Irradiation Reduces Brain Metastases and Improves Overall Survival in High-Risk Metastatic Non-Small Cell Lung Cancer Patients: A Randomized phase 2 Study (PRoT-BM trial). Arrieta O; Maldonado F; Turcott JG; Zatarain-Barrón ZL; Barrón F; Blake-Cerda M; Cabrera-Miranda LA; Cardona AF; de la Garza JG; Rosell R Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1442-1450. PubMed ID: 33640422 [TBL] [Abstract][Full Text] [Related]
9. Prophylactic Cranial Irradiation for Patients With Locally Advanced Non-Small-Cell Lung Cancer at High Risk for Brain Metastases. Park HS; Decker RH; Wilson LD; Yu JB Clin Lung Cancer; 2015 Jul; 16(4):292-7. PubMed ID: 25499149 [TBL] [Abstract][Full Text] [Related]
10. [Present role of prophylactic cranial irradiation]. Le Péchoux C; Al Mohkles H; Dhermain F Bull Cancer; 2013 Jan; 100(1):35-43. PubMed ID: 23306141 [TBL] [Abstract][Full Text] [Related]
11. A systematic review of risk factors for brain metastases and value of prophylactic cranial irradiation in non-small cell lung cancer. Sun DS; Hu LK; Cai Y; Li XM; Ye L; Hou HY; Wang CH; Jiang YH Asian Pac J Cancer Prev; 2014; 15(3):1233-9. PubMed ID: 24606446 [TBL] [Abstract][Full Text] [Related]
12. Cranial prophylactic irradiation in locally advanced non-small cell lung carcinoma: current status and future perspectives. Topkan E; Yildirim BA; Selek U; Yavuz MN Oncology; 2009; 76(3):220-8. PubMed ID: 19218826 [TBL] [Abstract][Full Text] [Related]
13. Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study. De Ruysscher D; Dingemans AC; Praag J; Belderbos J; Tissing-Tan C; Herder J; Haitjema T; Ubbels F; Lagerwaard F; El Sharouni SY; Stigt JA; Smit E; van Tinteren H; van der Noort V; Groen HJM J Clin Oncol; 2018 Aug; 36(23):2366-2377. PubMed ID: 29787357 [TBL] [Abstract][Full Text] [Related]
14. [Prophylactic cranial irradiation in non-small cell lung cancer]. Mazeron R; Le Péchoux C; Bruna A; Amarouch A; Bretel JJ; Ferreira I Cancer Radiother; 2007; 11(1-2):84-91. PubMed ID: 17005429 [TBL] [Abstract][Full Text] [Related]
15. Prophylactic Cranial Irradiation in Patients With High-Risk Metastatic Non-Small Cell Lung Cancer: Quality of Life and Neurocognitive Analysis of a Randomized Phase II Study. Maldonado F; Gonzalez-Ling A; Oñate-Ocaña LF; Cabrera-Miranda LA; Zatarain-Barrón ZL; Turcott JG; Flores-Estrada D; Lozano-Ruiz F; Cacho-Díaz B; Arrieta O Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):81-92. PubMed ID: 33915217 [TBL] [Abstract][Full Text] [Related]
16. Individual patient data meta-analysis of prophylactic cranial irradiation in locally advanced non-small cell lung cancer. Witlox WJA; Ramaekers BLT; Lacas B; Le Pechoux C; Pignon JP; Sun A; Wang SY; Hu C; Redman M; van der Noort V; Li N; Guckenberger M; van Tinteren H; Groen HJM; Joore MA; De Ruysscher DKM Radiother Oncol; 2021 May; 158():40-47. PubMed ID: 33587968 [TBL] [Abstract][Full Text] [Related]
17. Phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced non-small-cell lung cancer: primary analysis of radiation therapy oncology group study RTOG 0214. Gore EM; Bae K; Wong SJ; Sun A; Bonner JA; Schild SE; Gaspar LE; Bogart JA; Werner-Wasik M; Choy H J Clin Oncol; 2011 Jan; 29(3):272-8. PubMed ID: 21135270 [TBL] [Abstract][Full Text] [Related]
18. [Research progress of prophylactic cranial irradiation for locally advanced non-small cell lung cancer]. Cui Y; Li H; Zhang Y Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):1-3. PubMed ID: 26796798 [TBL] [Abstract][Full Text] [Related]
19. Risk factors for neurocognitive decline in lung cancer patients treated with prophylactic cranial irradiation: A systematic review. Zeng H; Hendriks LEL; van Geffen WH; Witlox WJA; Eekers DBP; De Ruysscher DKM Cancer Treat Rev; 2020 Aug; 88():102025. PubMed ID: 32512415 [TBL] [Abstract][Full Text] [Related]
20. Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects. Stuschke M; Eberhardt W; Pöttgen C; Stamatis G; Wilke H; Stüben G; Stöblen F; Wilhelm HH; Menker H; Teschler H; Müller RD; Budach V; Seeber S; Sack H J Clin Oncol; 1999 Sep; 17(9):2700-9. PubMed ID: 10561344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]